Saga Lifesciences Limited — Ambroxol Exporter Profile
Indian Pharmaceutical Exporter · #13 for Ambroxol · $241.9K export value · DGFT Verified
Saga Lifesciences Limited is the #13 Indian exporter of Ambroxol with $241.9K in export value and 34 verified shipments. Saga Lifesciences Limited holds a 1.6% market share in Ambroxol exports across 4 countries. The company exports 14 pharmaceutical products worth $7.5M across 8 therapeutic categories.
Saga Lifesciences Limited — Ambroxol Export Profile: Buyers & Destinations
Where Does Saga Lifesciences Limited Export Ambroxol?
| Country | Value | Shipments | Share |
|---|---|---|---|
| VENEZUELA | $185.1K | 23 | 76.5% |
| HONDURAS | $53.8K | 9 | 22.2% |
| PAKISTAN | $1.5K | 1 | 0.6% |
| AFGHANISTAN | $1.5K | 1 | 0.6% |
Saga Lifesciences Limited exports Ambroxol to 4 countries. The largest destination is VENEZUELA accounting for 76.5% of Saga Lifesciences Limited's Ambroxol shipments, followed by HONDURAS (22.2%) and PAKISTAN (0.6%). These destinations reflect Saga Lifesciences Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Ambroxol from Saga Lifesciences Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| TO THE ORDER | AFGHANISTAN | $51.8K | 9 |
| KANDAHAR | PAKISTAN | $1.5K | 1 |
Saga Lifesciences Limited supplies Ambroxol to 2 buyers globally. The largest buyer is TO THE ORDER (AFGHANISTAN). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Ambroxol Export Value and How Much Does Saga Lifesciences Limited Contribute?
India exported $7.8M worth of Ambroxol through 1,705 shipments from 296 suppliers to 92 countries, serving 486 buyers globally. Saga Lifesciences Limited contributes $241.9K to this total, accounting for 1.6% of India's Ambroxol exports. Saga Lifesciences Limited ships Ambroxol to 4 countries through 2 buyers.
What Is the Average Shipment Value for Saga Lifesciences Limited's Ambroxol Exports?
Saga Lifesciences Limited's average Ambroxol shipment value is $7.1K per consignment, based on 34 shipments totaling $241.9K. The largest destination is VENEZUELA (76.5% of Saga Lifesciences Limited's Ambroxol exports).
How Does Saga Lifesciences Limited Compare to Other Indian Ambroxol Exporters?
Saga Lifesciences Limited ranks #13 among 296 Indian Ambroxol exporters with a 1.6% market share. The top 3 exporters are WEXFORD LABORATORIES PRIVATE LIMITED ($1.4M), BIOMATRIX HEALTHCARE PRIVATE LIMITED ($1.1M), FOURRTS (INDIA) LABORATORIES PRIVATE LIMITED ($958.0K). Saga Lifesciences Limited processed 34 shipments to 4 destination countries.
What Ambroxol Formulations Does Saga Lifesciences Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| PHARMACEUTICAL PRODUCTS FOR HUMAN USE,HARMLESS MEDICINES AMBROXOL AND LORATADINESYRUP (AS PER INV) | $31.8K | 4 |
| PHARMACEUTICAL PRODUCTS AMBROXOL HYDROCH | $23.3K | 2 |
| PHARMACEUTICAL PRODUCTS FOR HUMAN USE, HARMLESS MEDICINES AMBROXOL HYDROCHLORIDESYRUP 30MG/5ML(PACK SIZE:-120ML)(PACKS | $20.7K | 1 |
| PHARMACEUTICAL PRODUCTS FOR HUMAN USE HARMLESS MEDICINES AMBROXOL HYDROCHLORIDESYRUP 30MG/5ML(33600 PACK) AS PER INVNOS | $20.6K | 3 |
| PHARMA.PRODUCTS FOR HUMAN USE,HARMLESS MEDICINES AMBROXOL HYDROCHLORIDE SYRUP 15MG/5ML(PACK SIZE-120 ML)33567 PACKSNOS | $15.1K | 3 |
| PHARMACEUTICAL PRODUCTS FOR HUMAN USE HARMLESS MEDICINES AMBROXOL HYDROCHLORIDESYRUP 15MG/5ML(PACK SIZE:-120ML)(33600 | $14.8K | 1 |
| PHARMACEUTICAL PRODUCTS FOR HUMAN USE, HARMLESS MEDICINES AMBROXOL HYDROCHLORIDESYRUP 15MG/5ML (AS PER INVOICE)PCS | $14.4K | 3 |
| PHARMACEUTICAL PRODUCTS FOR HUMAN USE HARMLESS MEDICINES AMBROXOL HYDROCHLORIDESYRUP AS PER INVOICE | $14.2K | 1 |
| PHARMA PRODUCTS FOR HUMAN USE, HARMLESSMEDICINES AMBROXOL HYDROCHLORIDE SYRUP PACK SIZE- 120ML (PACKS-30000) AS PER INV | $13.6K | 3 |
| PHARMACEUTICAL PRODUCTS AMBROXOL AND LOR | $12.8K | 1 |
Saga Lifesciences Limited exports 19 distinct Ambroxol formulations including tablets, capsules, syrups, and combination drugs. The top formulation is PHARMACEUTICAL PRODUCTS FOR HUMAN USE,HARMLESS MEDICINES AMB with 4 shipments worth $31.8K. Notable combination products include fixed-dose combinations with other active ingredients, meeting diverse global regulatory requirements.
How Does Saga Lifesciences Limited Compare to Nearest Ambroxol Exporters?
Exporters ranked immediately above and below #13 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 11 | CAPLIN POINT LABORATORIES LIMITED | $281.6K | 35 | 6 | $8.0K |
| 12 | SERENE HEALTH CARE PRIVATE LIMITED | $258.6K | 18 | 2 | $14.4K |
| 13 | SAGA LIFESCIENCES LIMITED ★ | $241.9K | 34 | 4 | $7.1K |
| 14 | AGIO PHARMACEUTICALS LIMITED | $241.6K | 14 | 2 | $17.3K |
| 15 | VANCE AND HEALTH PHARMACEUTICALS PRIVATE LIMITED | $221.0K | 127 | 1 | $1.7K |
Saga Lifesciences Limited ranks #13 among 296 Indian Ambroxol exporters. Average shipment value of $7.1K compared to the market average of $26.4K. The closest competitors by value are CAPLIN POINT LABORATORIES LIMITED and SERENE HEALTH CARE PRIVATE LIMITED.
Which Indian Ports Ship Ambroxol Exports?
| Port | Shipments | % Share |
|---|---|---|
| NHAVA SHEVA SEA (INNSA1) | 289 | 17.0% |
| JNPT | 116 | 6.8% |
| JNPT/ NHAVA SHEVA SEA | 115 | 6.7% |
| MUNDRA SEA (INMUN1) | 112 | 6.6% |
| SAHAR AIR CARGO ACC (INBOM4) | 109 | 6.4% |
| MUNDRA SEA | 86 | 5.0% |
| SAHAR AIR | 69 | 4.0% |
| AHEMDABAD ICD | 65 | 3.8% |
What Other Respiratory & OTC Products Does Saga Lifesciences Limited Export?
Saga Lifesciences Limited also exports these respiratory & otc products. Each links to the detailed product page.
About Saga Lifesciences Limited
Saga Lifesciences Limited exports 14 products worth $7.5M. Beyond Ambroxol, top products include Cefixime, Vitamin, Tramadol, Itraconazole, Dextromethorphan. View the complete Saga Lifesciences Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Ambroxol — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Ambroxol shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Saga Lifesciences Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 34 individual customs records matching Saga Lifesciences Limited exporting Ambroxol, covering 19 formulations to 4 countries via 2 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 92+ countries, 486+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Ambroxol Export Data from Saga Lifesciences Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Saga Lifesciences Limited's Ambroxol exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Saga Lifesciences Limited
Full Company Profile →
14 products · $7.5M total trade · 8 categories
Ambroxol Stats
Company Overview
Top Products by Saga Lifesciences Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Saga Lifesciences Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Ambroxol. For current shipment-level data, contact TransData Nexus.